ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway

Zhong, Renxing; Xia, Tianyi; Wang, Yi; Ding, Zihe; Li, Wei; Chen, Ying; Peng, Mingming; Li, Chuanqiu; Zhang, Han; Shu, Zunpeng*广东药学院
Journal of Ethnopharmacology2022-2-10DOI: 10.1016/j.jep.2021.114777
12被引7阅读
引用收藏
分享

摘要

Ethnopharmacological relevance: Physalin B (PB) is an active constituent of Physalis alkekengi L. var. Franchetii, which is a traditional medicine for clearing heat and detoxification, resolving phlegm, and diuresis. It has been commonly applied to treat sore throat, phlegm-heat, cough, dysuria, pemphigus, and eczema. @@@ Aim of study: Physalin B has shown efficacy as an anti-acute lung injury (ALI) agent previously; however, its mechanisms of action remain unclear. In the present study, we established a lipopolysaccharide-induced septic ALI model using BALB/c mice to further confirm the therapeutic potential of PB and to assess the underlying molecular mechanisms. @@@ Materials and methods: We used 75% ethanol and macroporous resin for extraction, separation, and enrichment of PB. The LPS-induced ALI mouse model was used to determine anti-inflammatory effects of PB. The severity of acute lung injury was evaluated by hematoxylin and eosin staining, wet/dry lung ratio, and myeloperoxidase (MPO) activity in lung tissue. An automatic analyzer was used to measure the arterial blood gas index. Protein levels of pro-inflammatory cytokines in serum, bronchoalveolar lavage fluid (BALF), and lung tissue was measured using an ELISA. Quantitative RT-PCR was used to measure changes in RNA levels of pro-inflammatory cytokines in the lungs. A fluorometric assay kit was used for determination of apoptosis-related factors to assess anti-apoptotic effects of PB. Western blotting was used to assess levels of key pathway proteins and apoptosisrelated proteins. Connections between the pathways were tested through inhibitor experiments. @@@ Results: Pretreatment with PB (15 mg kg(-1) d(-1), i.g.) significantly reduced lung wet/dry weight ratios and MPO activity in blood and BALF of ALI mice, and it alleviated LPS-induced inflammatory cell infiltration in lung tissue. The levels of pro-inflammatory factors TNF-alpha, IL-6, and IL-1 beta and their mRNA levels in blood, BALF, and lung tissue were reduced following PB pretreatment. PB pretreatment also downregulated the apoptotic factors caspase-3, caspase-9, and apoptotic protein Bax, and it upregulated apoptotic protein Bcl-2. The NF-kappa B and NLRP3 pathways were inhibited through activation of the PI3K/Akt pathway due to PB pretreatment, whereas administration of PI3K inhibitors increased activation of these pathways. @@@ Conclusions: Taken together, our results suggest that the anti-ALI properties of PB are closely associated with the inactivation of NF-kappa B and NLRP3 by altering the PI3K/Akt pathway. Furthermore, our findings provide a novel strategy for application of PB as a potential agent for treating patients with ALI. To the best of our knowledge, this is the first study to elucidate the underlying mechanism of action of PB against ALI.

学科与关键词

关键词
Acute lung injuryPhysalin BPI3K/Akt signaling pathwayNF-kappa BInflammasome NLRP3
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2022-02-10
卷期
第 284 卷
页码
114777
DOI
10.1016/j.jep.2021.114777
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Guangzhou Science and Technology Program in 2020 - Basic and Applied Basic Research Project [202002030226]; National Natural Science Foundation of China [81603366]; Natural Science Foundation of Guangdong Province-General Project [2021A1515011697]

作者

  • Z

    Zhong, Renxing (第一作者)

    guangdong pharmaceut univ

  • X

    Xia, Tianyi

    guangdong pharmaceut univ

查看全部 10 位作者收起作者
  • W

    Wang, Yi

    guangdong pharmaceut univ

  • D

    Ding, Zihe

    guangdong pharmaceut univ

  • L

    Li, Wei

    guangdong pharmaceut univ

  • C

    Chen, Ying

    guangdong pharmaceut univ

  • P

    Peng, Mingming

    guangdong pharmaceut univ

  • L

    Li, Chuanqiu

    guangdong pharmaceut univ

  • Z

    Zhang, Han

    jiamusi univ

  • S

    Shu, Zunpeng (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417